Evidence map›Paper›PMID 33210192›Full record

Trial reportJournal of general internal medicine2022

Impact of Metformin on Statin Persistence: a Post Hoc Analysis of a Large Randomized Controlled Trial.

Byron Cheon, Ambuj Kumar, Athanasios Tsalatsanis, Kevin Cowart, Ronald R Magness, Srinivas M Tipparaju, Nicholas W Carris

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of general internal medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Byron CheonMorsani College of Medicine, University of South Florida, 12901 Bruce B Downs Blvd., MDC 30, Tampa, FL, 33612, USA.
Ambuj KumarMorsani College of Medicine, University of South Florida, 12901 Bruce B Downs Blvd., MDC 30, Tampa, FL, 33612, USA.
Athanasios TsalatsanisMorsani College of Medicine, University of South Florida, 12901 Bruce B Downs Blvd., MDC 30, Tampa, FL, 33612, USA.
Kevin CowartTaneja College of Pharmacy, University of South Florida, 12901 Bruce B Downs Blvd., MDC 30, Tampa, FL, 33612, USA.
Ronald R MagnessMorsani College of Medicine, University of South Florida, 12901 Bruce B Downs Blvd., MDC 30, Tampa, FL, 33612, USA.
Srinivas M TipparajuTaneja College of Pharmacy, University of South Florida, 12901 Bruce B Downs Blvd., MDC 30, Tampa, FL, 33612, USA.
Nicholas W CarrisTaneja College of Pharmacy, University of South Florida, 12901 Bruce B Downs Blvd., MDC 30, Tampa, FL, 33612, USA. carris@usf.edu.ORCID 0000-0001-8904-5034

Funding

Protecting the Diabetic Skeletal Muscle by Nampt ActivationR01DK119066 · NIDDK · UNIVERSITY OF SOUTH FLORIDA · PI BROTTO, MARCO, TIPPARAJU, SRINIVAS M. · 2019 to 2023
$2.0M
Endothelial Function in a Model of IUGR Induced by Uterine Space RestrictionR01HL117341 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI MAGNESS, RONALD R · 2014 to 2017
$1.8M
NHLBI NIH HHS NIH HL117341NHLBI NIH HHS R01 HL117341NIDDK NIH HHS NIH DK119066NIDDK NIH HHS R01 DK119066
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 2Hydroxymethylglutaryl-CoA Reductase InhibitorsMetforminHumansHypoglycemic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsHypoglycemic AgentsMetformin

Identifiers

PMID33210192
PMCPMC8738786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.